Retatrutide is an investigational triple receptor agonist targeting GLP-1, GIP, and glucagon receptors, administered as a once-weekly subcutaneous injection for obesity and type 2 diabetes
You may be a suitable candidate if you: Have a BMI over 30 (or over 27 with weight-related health issues like high blood pressure, diabetes, or other cardiovascular risk factors) Struggle with food cravings and portion control Have insulin resistance or prediabetes Are looking for a long-term weight loss solution without dangerous side effects These medications are not a quick fix, but they provide lasting results when paired with healthy lifestyle habits
This blog discusses GLP-1 analogues, like semaglutide, Wegovy, Ozempic, Rybelsus, Retatrutide, and Tirzepatide, which are groundbreaking medications for managing weight loss and type 2 diabetes
To learn more about how GLP-1 medications fit into your weight loss program, contact a healthcare provider or consult with Boston Medical Group to create a personalized GLP-1 nutrition puzzle that aligns with your goals for effective weight loss treatment.
/assets/images/provider/photos/2775905.jpeg)
